BCWORLD PHARM. Co., Ltd. (KOSDAQ:A200780) announces a share repurchase program. Under the program, the company will repurchase shares up to 100,000 shares pursuant to a contract with Mirae Asset Securities. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until November 29, 2022. As of August 25, 2022, the company had 353,819 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchase.

On August 29, 2022, the company announced that the program will expire on November 28, 2022.